The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
RIVM report 650270002 Page 159 <strong>of</strong> 207<br />
Phenylethylamine<br />
(29) Karoum F, Potkin S, Chuang LW, Murphy DL, Liebowitz MR, Wyatt RJ.<br />
Phenylacetic acid excretion in schizophrenia and depression: the origins <strong>of</strong> PAA<br />
in man. Biological psychiatry, 1984; 19 (2):165-178.<br />
(30) Luthy J, Schlatter C. Biogene Amine in Lebensmitteln: Zur Wirkung von<br />
Histamin, Tyramin und Phenylethylamin auf den Menschen. [Biogenic amines<br />
in food: effects <strong>of</strong> histamine, tyramine and phenylethylamine in the human].<br />
Zeitschrift fur Lebensmittel Untersuchung und Forschung, 1983; 177 (6):439-<br />
443.<br />
(31) Ortmann R, Schaub M, Felner A, Lauber J, Christen P, Waldmeier PC.<br />
Phenylethylamine-induced stereotypies in the rat: a behavioral test system for<br />
assessment <strong>of</strong> MAO-B inhibi<strong>to</strong>rs. Psychopharmacology, 1984; 84 (1):22-27.<br />
(32) Dourish CT. An observational analysis <strong>of</strong> the behavioural effects <strong>of</strong> betaphenylethylamine<br />
in isolated and grouped mice. Progress in neuro<br />
psychopharmacology and biological psychiatry, 1982; 6 (2):143-158.<br />
(33) Dourish CT. Behavioural effects <strong>of</strong> acute and chronic beta-phenylethylamine<br />
administration in the rat: evidence for the involvement <strong>of</strong> 5-hydroxytryptamine.<br />
Neuropharmacology, 1981; 20 (11):1067-1072.<br />
(34) Denno KM, Sadler TW. Phenylalanine and its metabolites induce<br />
embryopathies in mouse embryos in culture. Tera<strong>to</strong>logy, 1990; 42 (5):565-570.<br />
(35) Yu PH, Durden DA, Davis BA, Boul<strong>to</strong>n AA. Interaction <strong>of</strong> biogenic amines<br />
with components <strong>of</strong> <strong>cigarette</strong> smoke. Formation <strong>of</strong> cyanomethylamine<br />
derivatives. Biochem Pharmacol, 1988; 37 (19):3729-3734.<br />
(36) Yu PH, Boul<strong>to</strong>n AA. Irreversible inhibition <strong>of</strong> monoamine oxidase by some<br />
components <strong>of</strong> <strong>cigarette</strong> smoke. Life Sci, 1987; 41 (6):675-682.<br />
(37) S<strong>to</strong>ltz M, Reynolds D, Elkins L, Salazar D, Weir S. Pharmacokinetics and<br />
pharmacodynamics <strong>of</strong> the monoamine oxidase B inhibi<strong>to</strong>r m<strong>of</strong>egiline assessed<br />
during a phase I dose <strong>to</strong>lerance trial. Clinical pharmacology and therapeutics,<br />
1995; 58 (3):342-353.<br />
(38) Greenshaw AJ. beta-Phenylethylamine and reinforcement. Progress in neuro<br />
psychopharmacology and biological psychiatry, 1984; 8 (4-6):615-620.<br />
(39) Shannon HE, Degregorio CM. Self-administration <strong>of</strong> the endogenous trace<br />
amines beta-phenylethylamine, N-methyl phenylethylamine and<br />
phenylethanolamine in dogs. <strong>The</strong> Journal <strong>of</strong> pharmacology and experimental<br />
therapeutics, 1982; 222 (1):52-60.<br />
(40) Bergman J, Yasar S, Winger G. Psychomo<strong>to</strong>r stimulant effects <strong>of</strong> betaphenylethylamine<br />
in monkeys treated with MAO-B inhibi<strong>to</strong>rs.<br />
Psychopharmacology, 2001; 159(1):21-30.
Change language